ATKINSON EDWARD MORROW III 1914164 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Atkinson Edward Morrow Iii | DIRECTOR | dsp | 6250.0 | 100.0 | 0.86 | 17.91 | Direct | Common Stock | 89BIO, INC. | code S | 0.0 | 72.87 (ETNB) |
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Atkinson Edward Morrow Iii | DIRECTOR | acq | 6250.0 | 100.0 | 0.86 | 2.61 | Direct | Common Stock | 89BIO, INC. | code M | 6250.0 | 72.87 (ETNB) |
| 2023-09-05 | 2023-08-29 | 3 | Atkinson Edward Morrow Iii | EVP, CHIEF TECHNICAL OPS. OFF. | holding | 13879.0 | 0 | 0.54 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | NA | 258.09 (VRTX) | ||
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Atkinson Edward Morrow Iii | EVP, CHIEF TECHNICAL OPS. OFF. | acq | 11003.0 | 44.22 | 0.43 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 24882.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 to 2024-02-12 | 4 | Atkinson Edward Morrow Iii | EVP, CHIEF TECHNICAL OPS. OFF. | dsp | 1745.0 | 7.01 | 0.07 | 421.43 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 23137.0
|
257.68 (VRTX) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Atkinson Edward Morrow Iii | EVP, CHIEF TECHNICAL OPS. OFF. | dsp | 3427.0 | 14.81 | 0.13 | 422.13 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 19710.0
|
258.31 (VRTX) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Atkinson Edward Morrow Iii | EVP, CHIEF TECHNICAL OPS. OFF. | dsp | 1201.0 | 6.09 | 0.05 | 421.77 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 18509.0 | 258.31 (VRTX) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 to 2024-02-26 | 4 | Atkinson Edward Morrow Iii | EVP, CHIEF TECHNICAL OPS. OFF. | dsp | 2537.0 | 13.71 | 0.1 | 429.67 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 15972.0
|
258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Atkinson Edward Morrow Iii | DIRECTOR | dsp | 6250.0 | 100.0 | 0.86 | 2.61 | Direct | Stock Option (Right To Buy) | 89BIO, INC. | code M | 0.0 | 72.87 (ETNB) |
| 2024-02-05 | 2024-02-01 | 2024-02-01 | 4 | Atkinson Edward Morrow Iii | DIRECTOR | acq | 45150.0 | 100.0 | 5.97 | 9.98 | Direct | Stock Option (Right To Buy) | 89BIO, INC. | code A | 45150.0 | 75.64 (ETNB) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)